| Date | Time | Source | Headline | Symbol | Company |
| 10/22/2010 | 12:56PM | Dow Jones News | Denmark's Zealand Pharma Set For Nov Partial Listing - Source | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/21/2010 | 5:01PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/21/2010 | 1:34PM | Dow Jones News | 2nd UPDATE:Lilly 3Q Net Up 38% After '09 Charges; EPS View Raised | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/21/2010 | 1:33PM | Dow Jones News | CORRECT: UPDATE: Lilly 3Q Net Jumps 38% After 2009 Charges; EPS View Raised | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/21/2010 | 10:03AM | Dow Jones News | UPDATE: Lilly 3Q Net Jumps 38% After 2009 Charges; EPS View Raised | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2010 | 9:46PM | Dow Jones News | 2nd UPDATE: FDA Again Denies Approval For Long-Acting Byetta | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2010 | 8:13PM | Dow Jones News | UPDATE: FDA Requests Heart-Rate Test For Amylin, Eli, Alkermes Diabetes Drug | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2010 | 7:39PM | Dow Jones News | FDA Requests Heart-Rate Test For Amylin, Eli, Alkermes Diabetes Drug | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2010 | 7:06PM | PR Newswire (US) | Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly Update Conference Call Canceled | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2010 | 6:40PM | PR Newswire (US) | Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™ | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/15/2010 | 4:13PM | Dow Jones News | Diabetes Drug's Approval Expected, But Impact Still Uncertain | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/13/2010 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Third Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/13/2010 | 12:01PM | Dow Jones News | Alkermes Gets Vivitrol Approval, Investors Focus Elsewhere | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/12/2010 | 7:36PM | Dow Jones News | Alkermes: FDA Widens Approved Use Of Vivitrol For Opioid Addiction | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/05/2010 | 5:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/05/2010 | 5:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/05/2010 | 5:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/05/2010 | 5:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/30/2010 | 4:33AM | Dow Jones News | Sanofi Reports Good Diabetes Drug Results Ahead Of R&D Day | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/14/2010 | 4:30PM | PR Newswire (US) | BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/08/2010 | 8:34AM | Dow Jones News | BioMed Realty Trust Acquiring San Diego Portfolio For $132.9 Million | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/07/2010 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and Baird Global Healthcare Conferences | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/23/2010 | 2:07PM | Dow Jones News | INTERVIEW: Novo Nordisk To Test Victoza In Anti-Obesity - CEO | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/19/2010 | 9:52AM | Marketwired | Analyst Research on Dendreon and Amylin Pharmaceuticals - Biotech Stocks Looking Averagely Attractive | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/16/2010 | 3:29PM | Dow Jones News | UPDATE: Icahn Increases Exposure To Energy Companies In 2Q | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/16/2010 | 1:32PM | Dow Jones News | Icahn Increases Exposure To Energy Companies In 2Q | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/13/2010 | 12:05PM | Dow Jones News | Lilly's Latest Patent Loss Pressures Its Deal-Making Efforts | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/05/2010 | 4:06PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/27/2010 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/21/2010 | 4:12PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |